ABBVIE SUBMITS BIOLOGICS LICENSE APPLICATION TO THE FDA FOR TELISOTUZUMAB VEDOTIN (TELISO-V) IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER

Reuters · 5d ago
ABBVIE SUBMITS BIOLOGICS LICENSE APPLICATION TO THE FDA FOR TELISOTUZUMAB VEDOTIN (TELISO-V) IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER